10-Q: ACM Research Q2 2025 Revenue Up 6.4%, Net Income Rises
Quarterly Report
ACM Research reports increased revenue and net income for Q2 2025, driven by strong demand in single wafer cleaning and ECP technologies.
Summary
- Revenue for the three months ended June 30, 2025, was $215.372 million, a 6.4% increase from $202.480 million in the same period of 2024.
- Revenue for the six months ended June 30, 2025, was $387.719 million, a 9.3% increase from $354.671 million in the same period of 2024.
- Net income attributable to ACM Research, Inc. for the three months ended June 30, 2025, was $29.760 million, up 22.9% from $24.210 million in the prior year.
- Net income attributable to ACM Research, Inc. for the six months ended June 30, 2025, was $50.140 million, up 20.4% from $41.643 million in the prior year.
- Basic earnings per share for Q2 2025 increased to $0.47 from $0.39, and diluted EPS rose to $0.44 from $0.35.
- Gross margin for Q2 2025 was 48.5%, an increase from 47.8% in Q2 2024, but for H1 2025, it decreased to 48.2% from 49.6% in H1 2024.
- Operating expenses for Q2 2025 increased by 22.9% to $72.767 million, and for H1 2025, they increased by 14.6% to $129.540 million.
- Total shipments for the six months ended June 30, 2025, decreased to $363.1 million from $448.2 million in the same period of 2024.
- Net cash used in operating activities for the six months ended June 30, 2025, was ($39.619) million, compared to $51.942 million provided in the prior year period.
- Cash and cash equivalents, restricted cash, and time deposits totaled $483.905 million as of June 30, 2025, an increase of $42.0 million from December 31, 2024.
Sentiment
Score: 7
Explanation: The company demonstrated strong revenue and net income growth, indicating solid market demand for its products. However, this is tempered by a decrease in total shipments, negative operating cash flow, and increased operating expenses. Significant geopolitical and regulatory risks, particularly concerning China operations and U.S. export controls, introduce uncertainty. The company's strategic expansion and government support are positive, but the operational and external challenges warrant a moderately positive outlook.
Positives
- Revenue increased across all product categories for both the three and six months ended June 30, 2025.
- ECP (front-end and packaging), furnace, and other technologies revenue grew significantly by 23.2% in Q2 2025 and 16.8% in H1 2025.
- Net income attributable to ACM Research, Inc. showed strong growth, increasing by 22.9% in Q2 2025 and 20.4% in H1 2025.
- Gross margin improved slightly in Q2 2025 to 48.5% from 47.8% in Q2 2024.
- Interest income increased substantially by 68.5% in Q2 2025 and 76.9% in H1 2025.
- Income from equity method investments saw a significant increase of 355.1% in Q2 2025 and 324.3% in H1 2025.
- Net cash provided by financing activities was robust at $110.973 million for the six months ended June 30, 2025.
- ACM Shanghai benefits from a preferential income tax rate of 15% as an advanced and new technology enterprise, effective until December 31, 2026.
- ACM Shanghai continues to receive various government grants for technology development and its R&D and production center.
Negatives
- Operating expenses increased significantly by 22.9% in Q2 2025 and 14.6% in H1 2025, outpacing revenue growth.
- Sales and marketing expenses rose by 29.0% in Q2 2025 and 22.8% in H1 2025.
- Research and development expenses increased by 30.2% in Q2 2025 and 22.9% in H1 2025.
- Gross margin for the six months ended June 30, 2025, decreased to 48.2% from 49.6% in the prior year, partly due to a higher provision for inventory.
- Total shipments for the six months ended June 30, 2025, decreased by 19.0% to $363.1 million from $448.2 million in the prior year period.
- First tool shipments for the six months ended June 30, 2025, decreased by 10.4% to $195.1 million from $217.7 million in the prior year period.
- Net cash used in operating activities for the six months ended June 30, 2025, was ($39.619) million, a significant decline from $51.942 million provided in the prior year period.
- Other (expense) income, net, turned negative in both Q2 and H1 2025, primarily due to foreign exchange losses.
Risks
- Mainland China central government authorities may require ACM Shanghai to obtain permission or approval to continue listing ACM Research's Class A common stock in the U.S., or changes in laws/interpretations could impose new restrictions, materially affecting the business and stock price.
- Mainland China central government authorities may intervene in or influence ACM Shanghai's operations at any time, with rules and regulations changing quickly and with little notice.
- The mainland China central government may exert additional control over overseas offerings or foreign investment in mainland China-based issuers, potentially causing significant declines in ACM Research Class A common stock value.
- Failure to obtain or maintain required operating permits and licenses in mainland China could lead to restrictions and penalties imposed by regulatory authorities.
- The addition of ACM Shanghai and ACM Korea to the BIS Entity List prohibits furnishing U.S. export-controlled hardware, software, or technologies without authorization, potentially impacting operations.
- The U.S. Outbound Investment Security Program (OISP) may limit cross-border investment opportunities, especially those related to China.
- The HFCA Act could lead to delisting of ACM Research's securities if the PCAOB is unable to inspect its auditor for two consecutive years.
- Covenants in the Lingang Grant Contract require minimum annual sales or tax payments by July 9, 2027; failure could result in liquidated damages or termination of the agreement.
- Certain loan covenants require ACM Shanghai's year-end outstanding interest-bearing debt not to exceed five times its annual EBITDA; failure could lead to facility suspension or accelerated repayment.
- A loan from China Merchants Bank requires ACM Shanghai to complete a Private Offering with more than RMB 900 million proceeds before January 2028, or face accelerated repayment.
- An ongoing investigation by the Seoul Customs Office regarding certain goods produced and shipped by ACM Korea to overseas markets, with an uncertain outcome, could potentially impact the company.
- Restrictions under mainland China laws and regulations, as well as ACM Shanghai's bank loan agreements, may significantly restrict ACM Shanghai's ability to transfer net assets to ACM Research or its other subsidiaries.
Future Outlook
Management anticipates continued increases in sales and marketing, research and development, and general and administrative expenses as the company expands its customer base, product portfolio, and global R&D team, and manages its public company operations in both the U.S. and mainland China. Gross margin is expected to remain between 42.0% and 48.0% for the foreseeable future. A substantial majority of revenue from semiconductor manufacturing equipment sales is expected to continue originating from customers in Asia. The company believes its current liquidity, including cash, time deposits, operating cash flow, and bank borrowings, will be sufficient to meet anticipated cash needs for at least the next 12 months. The effects of the recently signed One Big Beautiful Bill Act (OBBBA) on U.S. federal tax law are expected to be reflected in the financial statements for the three-month period ending September 30, 2025.
Management Comments
- The increase in revenue is attributed to a longer-term commitment by mainland China-based customers to increase production capacity to achieve a greater share of the global semiconductor market, alongside market share changes and product cycles.
- Gross margin is expected to be between 42.0% and 48.0% for the foreseeable future.
- Sales and marketing expenses are expected to increase in dollars as the company incurs additional costs associated with growing its customer base in mainland China and regions outside of mainland China.
- Research and development expenses are expected to increase in dollars as the company incurs additional costs to expand its product portfolio to address additional production steps and expand its research and development team to new regions.
- General and administrative expenses are expected to increase in dollars as the company incurs additional costs associated with growing its business, operating as a public company in the United States, and operating ACM Shanghai as a public company in mainland China.
- Existing cash and cash equivalents, time deposits, cash flow from operating activities, and bank borrowings are believed to be sufficient to meet anticipated cash needs for at least the next 12 months.
- ACM Research has never declared or paid cash dividends on its capital stock and intends to retain all available funds and future earnings to support business growth and development, not anticipating paying any cash dividends in the foreseeable future.
Industry Context
Gartner estimates the total worldwide semiconductor Wafer Fab Equipment (WFE) market grew by 8.6% from $102.8 billion in 2023 to $111.6 billion in 2024, and is projected to increase by 4.7% to $116.8 billion in 2025. The China WFE market, after growing 21.1% from $33.3 billion in 2023 to $40.4 billion in 2024, is expected to decrease by 17.1% to $33.5 billion in 2025. ACM Research's current product portfolio addresses an estimated $20 billion of the 2025 global WFE market, with significant opportunities in wafer cleaning, PECVD, Track, furnace, and ECP equipment. The company's revenue growth is linked to mainland China-based customers' commitment to increasing production capacity to gain global semiconductor market share.
Comparison to Industry Standards
- ACM Research's product portfolio addresses approximately $20 billion of the 2025 global Wafer Fab Equipment (WFE) market, indicating a substantial addressable market.
- The company's wafer cleaning equipment addresses an estimated $7.0 billion market opportunity.
- Plasma-Enhanced Chemical Vapor Deposition (PECVD) equipment addresses an estimated $5.1 billion market opportunity.
- Track equipment addresses an estimated $2.9 billion market opportunity.
- Furnace equipment addresses an estimated $2.6 billion market opportunity.
- Electro-chemical plating (ECP) equipment addresses an estimated $1.4 billion market opportunity.
- Stress-free polishing, advanced packaging, wafer processing, and other processing equipment address more than $1.2 billion market opportunity.
Legal Proceedings
- ACM Korea received inquiries from the Seoul Customs Office regarding certain goods produced and shipped to overseas markets. The investigation is ongoing and in its preliminary stages. The company does not believe it will have a material effect on its consolidated financial condition or results of operations at this time.
Related Party Transactions
- Purchases of materials from Ninebell, an equity investee and principal supplier, totaled $18.201 million for Q2 2025 and $27.013 million for H1 2025. Advances to Ninebell were $244 thousand, and accounts payable to Ninebell were $13.628 million as of June 30, 2025.
- Purchases of components from Shengyi, an equity investee and component supplier, totaled $4.082 million for Q2 2025 and $5.986 million for H1 2025. Service fees charged by Shengyi were $1.626 million for Q2 2025 and $1.899 million for H1 2025. Advances to Shengyi were $438 thousand, and accounts payable to Shengyi were $6.199 million as of June 30, 2025.
Stakeholder Impact
- Shareholders face potential dilution from ACM Shanghai's proposed private offering, which could reduce ACM Research's equity interest from 81.1% to approximately 74.6%.
- Shareholders may receive dividends from ACM Shanghai, with an aggregate total of approximately $40.1 million approved, though the timing and repatriation to the U.S. are uncertain.
- Employees are impacted by increased personnel costs in sales and marketing and R&D, and stock-based compensation remains a significant part of the compensation strategy.
- Customers, particularly those in mainland China, are demonstrating a longer-term commitment to increasing production capacity, driving revenue growth for the company.
- Suppliers like Ninebell and Shengyi continue to be key partners, with significant material purchases and service fees.
- Creditors are affected by new long-term loan facilities and associated covenants, which require specific financial performance metrics (e.g., EBITDA ratio) and the completion of a private offering to avoid accelerated repayment schedules.
Next Steps
- ACM Shanghai's proposed private offering is subject to market conditions, stockholder approval, Shanghai Stock Exchange review, and China Securities Regulatory Commission registration.
- ACM Shanghai expects to pay the approved dividend of approximately RMB 288.3 million (approximately $40.1 million) to its stockholders by the end of 2025.
- ACM Research expects to begin reflecting the effects of the One Big Beautiful Bill Act (OBBBA) in its consolidated financial statements for the three-month period ended September 30, 2025.
- ACM Lingang expects to enter into supplementary land grant agreements to formally adjust performance terms, including the extension of Construction Completion and Production Start Milestones for the Lingang Grant Contract.
- The company plans to continue expanding its direct sales teams and increasing global marketing activities to address customers in North America, Western Europe, and Southeast Asia.
- The company intends to expand its product portfolio and research and development team to new regions.
- ACM Shanghai expects to continue taking advantage of government-sponsored grant and subsidy programs.
- The Seoul Customs Office investigation into ACM Korea regarding certain goods produced and shipped to overseas markets is ongoing, with further developments expected.
Key Dates
| Date | Description |
|---|---|
| 1998 | ACM Research, Inc. founded in California. |
| 2005-05 | ACM Research (Shanghai), Inc. (ACM Shanghai) formed. |
| 2008 | ACM Shanghai began receiving various government grants. |
| 2009 | Delivered more than 1,255 tools to customers. |
| 2011-07 | ACM Research (Wuxi), Inc. formed. |
| 2012 | ACM Shanghai certified as an advanced and new technology enterprise. |
| 2016 | ACM Shanghai re-certified as an advanced and new technology enterprise. |
| 2017-06 | CleanChip Technologies Limited formed. |
| 2017-12 | ACM Research Korea CO., LTD. formed. |
| 2018 | ACM Shanghai re-certified as an advanced and new technology enterprise. |
| 2019-03 | ACM Research (Lingang), Inc. formed. |
| 2019-04 | ACM Research (CA), Inc. formed. |
| 2019-04 | ACM Research (Cayman), Inc. formed. |
| 2019-06 | ACM Shanghai invested in Shengyi Semiconductor Technology Co., Ltd. |
| 2019-09 | ACM Shanghai invested in Hefei Shixi Chanheng Integrated Circuit Industry Venture Capital Fund Partnership (LP). |
| 2019 | ACM Shanghai sold 8.3% of its outstanding shares. |
| 2020-07 | ACM Lingang obtained Land Use Right for its R&D and production center. |
| 2021 | ACM Shanghai re-certified as an advanced and new technology enterprise. |
| 2021 | ACM Shanghai sold an additional 10% of its outstanding shares in its STAR IPO. |
| 2021-08 | ACM Research (Singapore) PTE. Ltd. formed. |
| 2022-01-01 | Section 174 change by the Tax Cuts and Jobs Act of 2017 became effective. |
| 2022-02 | ACM Research (Beijing), Inc. formed. |
| 2022-03 | Hanguk ACM CO., LTD formed. |
| 2022-08 | ACM Singapore invested in Wooil Flucon Co. |
| 2023-06 | ACM-Wooil Microelectronics (Shanghai) Co., Ltd. formed. |
| 2023-06 | Yusheng Micro Semiconductor (Shanghai) Co., Ltd. formed. |
| 2023-07 | ACM Shanghai entered into a long-term loan facility with China CITIC Bank. |
| 2023-08 | ACM Shanghai entered into a long-term loan facility with China CITIC Bank. |
| 2023-09 | ACM Shanghai invested in Shengyi Semiconductor Technology Co., Ltd. (measurement alternative). |
| 2023-09 | ACM Shanghai invested in Company A. |
| 2023-11 | ACM Shanghai invested in Company B. |
| 2023-12 | FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). |
| 2024-01 | ACM Shanghai announced its intended plan for a private offering. |
| 2024-02 | ACM Shanghai invested in Company C. |
| 2024-02 | ACM Shanghai invested in Company D. |
| 2024-04 | ACM Lingang entered into a long-term loan facility with the Agricultural Bank of China. |
| 2024-04 | ACM Shanghai invested in Company E. |
| 2024-04-22 | ACM Shanghai entered into an investment agreement with Ninebell. |
| 2024-08 | ACM Shanghai entered into a long-term loan facility with China Merchants Bank. |
| 2024-09 | ACM Shanghai entered into a long-term loan facility with Bank of China. |
| 2024-11 | ACM Shanghai entered into a long-term loan facility with Industrial and Commercial Bank of China. |
| 2024-11 | ACM Shanghai entered into a long-term loan facility with Bank of China. |
| 2024-12 | FASB issued ASU 2024-03: Income Statement--Reporting Comprehensive Income--Expense Disaggregation Disclosures (Subtopic 220-40). |
| 2024-12 | ACM Shanghai invested in Company F. |
| 2024-12 | ACM Shanghai invested in Company G. |
| 2024-12 | ACM Research (Chengdu), Inc. formed. |
| 2024-12 | Shengyi Micro Semiconductor (Shanghai) Co., Ltd. formed. |
| 2024-12-02 | U.S. Department of Commerce's BIS promulgated a final rule naming ACM Shanghai and ACM Korea to the BIS Entity List. |
| 2024-12 | ACM Shanghai re-certified as an advanced and new technology enterprise. |
| 2025-01-01 | Share certificate for Ninebell issued after share purchase transaction closed. |
| 2025-01-02 | The U.S. Outbound Investment Security Program (OISP) became effective. |
| 2025-01 | ACM Research entered into a long-term loan facility with China CITIC Bank. |
| 2025-02 | ACM Shanghai drew down $20,955 under the Industrial and Commercial Bank of China facility. |
| 2025-04 | ACM Shanghai drew down another $20,955 under the Industrial and Commercial Bank of China facility. |
| 2025-05-15 | Sotheara Cheav, Senior Vice President, Manufacturing, adopted a Rule 10b5-1 trading arrangement. |
| 2025-05-20 | Jian Wang, CEO and President of ACM Shanghai, adopted a Rule 10b5-1 trading arrangement. |
| 2025-06 | ACM Shanghai entered into a long-term loan facility with Bank of China. |
| 2025-06-12 | ACM Shanghai held its Annual Stockholder Meeting and approved a proposed dividend. |
| 2025-06-30 | End of the quarterly period covered by this report. |
| 2025-07-04 | The One Big Beautiful Bill Act (OBBBA) was signed into law. |
| 2025-08-04 | Latest practicable date for Class A and Class B Common Stock shares outstanding count. |
| 2025-08-07 | Date of filing of this Quarterly Report on Form 10-Q. |
| 2025-08-15 | Sotheara Cheav's Rule 10b5-1 trading arrangement commences. |
| 2025-08-20 | Jian Wang's Rule 10b5-1 trading arrangement commences. |
| 2025-09-30 | Expected period for reflecting the effects of the OBBBA legislation in consolidated financial statements. |
| 2025-12-16 | Industrial Bank of Korea line of credit due. |
| 2025-12-31 | Expected payment of ACM Shanghai's approved dividend. |
| 2026-03-12 | China Merchants Bank lines of credit due. |
| 2026-04-14 | Bank of China line of credit due. |
| 2026-05-16 | Sotheara Cheav's Rule 10b5-1 trading arrangement termination date. |
| 2026-05-20 | Jian Wang's Rule 10b5-1 trading arrangement termination date. |
| 2026-06-30 | Bank of Shanghai line of credit due. |
| 2026-12-15 | ASU 2024-03 effective for fiscal years beginning after this date. |
| 2026-12-31 | ACM Shanghai's preferential income tax rate is effective until this date. |
| 2027-07-09 | Deadline for meeting annual sales or tax payment covenants under the Lingang Grant Contract. |
| 2027-11 | Industrial and Commercial Bank of China loan final maturity. |
| 2028-01 | Deadline for ACM Shanghai to complete a Private Offering of over RMB 900 million to avoid accelerated loan repayment from China Merchants Bank. |
| 2028-01 | China CITIC Bank loan final maturity. |
| 2028-06 | Bank of China loan final maturity. |
| 2030-11 | China Merchants Bank loan final maturity. |
| 2034-04 | Agricultural Bank of China loan final maturity. |
| 2034-06 | Bank of China loan final maturity. |
| 2034-08 | China Merchants Bank loan final maturity. |
Recommendation
holdWhile ACM Research reported strong revenue and net income growth, indicating robust demand for its semiconductor equipment, several factors warrant a cautious 'hold' recommendation. The decline in total shipments and negative operating cash flow for the first half of 2025, coupled with significantly increased operating expenses, suggest underlying operational challenges. Furthermore, the company faces substantial geopolitical and regulatory risks, particularly concerning its extensive operations in China and the impact of U.S. export controls and investment restrictions. The proposed private offering by ACM Shanghai, while a potential capital infusion, also introduces the risk of dilution for ACM Research shareholders. Given the mixed financial performance and the high-stakes external environment, a 'hold' position allows investors to monitor how these risks and operational dynamics evolve before making further investment decisions.
Keywords
Semiconductor equipment, Wafer fab equipment, WFE, Wafer cleaning, ECP, Advanced packaging, China semiconductor, ACMR, 10-Q, Financial results, Semiconductor industry, Capital equipment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.